These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 18459462)

  • 21. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
    Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective randomized trial of everolimus-eluting stents versus bare-metal stents in octogenarians: the XIMA Trial (Xience or Vision Stents for the Management of Angina in the Elderly).
    de Belder A; de la Torre Hernandez JM; Lopez-Palop R; O'Kane P; Hernandez Hernandez F; Strange J; Gimeno F; Cotton J; Diaz Fernandez JF; Carrillo Saez P; Thomas M; Pinar E; Curzen N; Baz JA; Cooter N; Lozano I; Skipper N; Robinson D; Hildick-Smith D;
    J Am Coll Cardiol; 2014 Apr; 63(14):1371-5. PubMed ID: 24216285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of sirolimus-eluting stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: 7-year follow-up of a randomized trial.
    Blazek S; Rossbach C; Borger MA; Fuernau G; Desch S; Eitel I; Stiermaier T; Lurz P; Holzhey D; Schuler G; Mohr FW; Thiele H
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):30-8. PubMed ID: 25499302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
    Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of unprotected left main disease with drug-eluting stents in patients at high risk for coronary artery bypass grafting.
    Barlis P; Horrigan M; Elis S; Chan R; Wong M; Farouque O; Proimos G; Ajani AE; Clark DJ
    Cardiovasc Revasc Med; 2007; 8(2):84-9. PubMed ID: 17574165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
    Lee JY; Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Park SW; Park SJ
    J Am Coll Cardiol; 2009 Aug; 54(9):853-9. PubMed ID: 19695467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry].
    Zahn R; Hamm CW; Zeymer U; Schneider S; Nienaber CA; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Schöbel WA; Sabin G; Senges J;
    Herz; 2004 Mar; 29(2):181-6. PubMed ID: 15057439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coronary artery bypass graft surgery versus drug-eluting stents for patients with isolated proximal left anterior descending disease.
    Hannan EL; Zhong Y; Walford G; Holmes DR; Venditti FJ; Berger PB; Jacobs AK; Stamato NJ; Curtis JP; Sharma S; King SB
    J Am Coll Cardiol; 2014 Dec; 64(25):2717-26. PubMed ID: 25541122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimally invasive direct coronary artery bypass improves late survival compared with drug-eluting stents in isolated proximal left anterior descending artery disease: a 10-year follow-up, single-center, propensity score analysis.
    Benedetto U; Raja SG; Soliman RF; Albanese A; Jothidasan A; Ilsley CD; Amrani M;
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1316-22. PubMed ID: 24521955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minimally invasive coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty with stenting in isolated high-grade stenosis of the proximal left anterior descending coronary artery: six months' angiographic and clinical follow-up of a prospective randomized study.
    Drenth DJ; Winter JB; Veeger NJ; Monnink SH; van Boven AJ; Grandjean JG; Mariani MA; Boonstra PW
    J Thorac Cardiovasc Surg; 2002 Jul; 124(1):130-5. PubMed ID: 12091818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Revascularization of left anterior descending artery with drug-eluting stents: comparison with minimally invasive direct coronary artery bypass surgery.
    Ben-Gal Y; Mohr R; Braunstein R; Finkelstein A; Hansson N; Hendler A; Moshkovitz Y; Uretzky G
    Ann Thorac Surg; 2006 Dec; 82(6):2067-71. PubMed ID: 17126111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial.
    Di Lorenzo E; Sauro R; Varricchio A; Carbone G; Cortese G; Capasso M; Lanzillo T; Manganelli F; Mariello C; Siano F; Pagliuca MR; Stanco G; Rosato G; De Luca G
    Circulation; 2009 Sep; 120(11):964-72. PubMed ID: 19720939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography.
    Gonzalo N; Barlis P; Serruys PW; Garcia-Garcia HM; Onuma Y; Ligthart J; Regar E
    JACC Cardiovasc Interv; 2009 May; 2(5):445-52. PubMed ID: 19463469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
    Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
    Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug eluting stents for the treatment of bare metal in-stent restenosis: long-term outcomes in real world practice.
    Appleby CE; Khattar RS; Morgan K; Clarke B; Curzen N; Neyses L; Fath-Ordoubadi F
    EuroIntervention; 2011 Jan; 6(6):748-53. PubMed ID: 21205600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents.
    Sawhney N; Moses JW; Leon MB; Kuntz RE; Popma JJ; Bachinsky W; Bass T; DeMaio S; Fry E; Holmes DR; Teirstein PS
    Circulation; 2004 Jul; 110(4):374-9. PubMed ID: 15249503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stenting of unprotected left main coronary artery in patients with low preoperative risk of coronary artery bypass grafting.
    Dudek D; Heba G; Giszterowicz D; Rzeszutko Ł; Legutko J; Bartuś S; Chyrchel M; Dubiel JS
    Kardiol Pol; 2006 Sep; 64(9):929-36; discussion 937-8. PubMed ID: 17054024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How to treat diabetic patients with multivesseal disease in the DES era.
    Pagnotta P; Cabbavale M; Briguori C
    Minerva Cardioangiol; 2006 Oct; 54(5):557-69. PubMed ID: 17019393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of distal/bifurcation left main restenosis after drug eluting stents implantation: single center experience.
    Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Vassilev D; Fraccaro C; Roncon L; Faggian G
    Cardiovasc Revasc Med; 2014 Mar; 15(2):76-9. PubMed ID: 24560299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results and predictors of angiographic restenosis and long-term adverse cardiac events after drug-eluting stent implantation for aorto-ostial coronary artery disease.
    Park DW; Hong MK; Suh IW; Hwang ES; Lee SW; Jeong YH; Kim YH; Lee CW; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2007 Mar; 99(6):760-5. PubMed ID: 17350360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.